rs376606287
Variant names:
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_145207.3(AFG2A):c.1278-10T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000185 in 1,593,370 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00016 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00019 ( 0 hom. )
Consequence
AFG2A
NM_145207.3 intron
NM_145207.3 intron
Scores
2
Splicing: ADA: 0.0001980
2
Clinical Significance
Conservation
PhyloP100: 1.90
Publications
1 publications found
Genes affected
AFG2A (HGNC:18119): (AFG2 AAA ATPase homolog A) This gene encodes a member of the ATPase associated with diverse activities family, whose members are defined by a highly conserved ATPase domain. Members of this family participate in diverse cellular processes that include membrane fusion, DNA replication, microtubule severing, and protein degradation. The protein encoded by this gene has a putative mitochondrial targeting sequence and has been proposed to function in maintenance of mitochondrial function and integrity during mouse spermatogenesis. Allelic variants in this gene have been associated with epilepsy, hearing loss, and cognitive disability syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016]
AFG2A Gene-Disease associations (from GenCC):
- microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, PanelApp Australia
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 4-122936090-T-C is Benign according to our data. Variant chr4-122936090-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 542394.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population sas. GnomAdExome4 allele frequency = 0.000187 (270/1441032) while in subpopulation SAS AF = 0.00146 (119/81594). AF 95% confidence interval is 0.00125. There are 0 homozygotes in GnomAdExome4. There are 153 alleles in the male GnomAdExome4 subpopulation. Median coverage is 29. This position passed quality control check.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AFG2A | ENST00000274008.5 | c.1278-10T>C | intron_variant | Intron 6 of 15 | 1 | NM_145207.3 | ENSP00000274008.3 | |||
AFG2A | ENST00000422835.2 | n.1320-10T>C | intron_variant | Intron 6 of 14 | 1 | |||||
AFG2A | ENST00000675612.1 | c.1275-10T>C | intron_variant | Intron 6 of 16 | ENSP00000502453.1 | |||||
AFG2A | ENST00000674886.1 | n.1340-10T>C | intron_variant | Intron 6 of 10 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152220Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
26
AN:
152220
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000253 AC: 61AN: 240696 AF XY: 0.000308 show subpopulations
GnomAD2 exomes
AF:
AC:
61
AN:
240696
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000187 AC: 270AN: 1441032Hom.: 0 Cov.: 29 AF XY: 0.000214 AC XY: 153AN XY: 715850 show subpopulations
GnomAD4 exome
AF:
AC:
270
AN:
1441032
Hom.:
Cov.:
29
AF XY:
AC XY:
153
AN XY:
715850
show subpopulations
African (AFR)
AF:
AC:
2
AN:
32908
American (AMR)
AF:
AC:
0
AN:
41862
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25658
East Asian (EAS)
AF:
AC:
0
AN:
39166
South Asian (SAS)
AF:
AC:
119
AN:
81594
European-Finnish (FIN)
AF:
AC:
4
AN:
52918
Middle Eastern (MID)
AF:
AC:
4
AN:
5658
European-Non Finnish (NFE)
AF:
AC:
131
AN:
1101796
Other (OTH)
AF:
AC:
10
AN:
59472
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
12
24
35
47
59
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.000164 AC: 25AN: 152338Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74502 show subpopulations
GnomAD4 genome
AF:
AC:
25
AN:
152338
Hom.:
Cov.:
32
AF XY:
AC XY:
14
AN XY:
74502
show subpopulations
African (AFR)
AF:
AC:
2
AN:
41582
American (AMR)
AF:
AC:
0
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5190
South Asian (SAS)
AF:
AC:
2
AN:
4830
European-Finnish (FIN)
AF:
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
21
AN:
68030
Other (OTH)
AF:
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not specified Uncertain:1
Dec 15, 2017
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome Benign:1
Jan 08, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.